A retrospective study was performed to evaluate the results of dermatologic radiotherapy in a large series of @entity1 affected by primary @entity1892 . The study included 104 @entity1 with @entity42424 treated with orthovoltage radiotherapy from 1973 to 2000. The total doses ranged from 14 to 35 Gy (mean 23.55 Gy). Results regarded 102 @entity1 (mean follow-up 65.08 months). Complete remission was observed in all cases; 76 @entity1 experienced a relapse after a mean interval of 22.03 months following radiotherapy, with a relapse-free rate of 22.82 % after 5 years. Extracutaneous progression was observed in 9 cases (8.82 %). An overall actuarial survival rate of 97.36 % was observed after 5 years. A salvage treatment of relapses brought 44 cases to remission. Although we have observed a relapse-free rate lower than that reported by others, dermatologic radiotherapy was "curative" in 25.49 % of cases. Such treatment appears particularly useful in the cases with few lesions and in the management of new cutaneous localizations of follicular center cell lymphoma.

Dermatologic radiotherapy of primary XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1892 :: ('MESH:D016393', 'Disease') :: ['cutaneous B-cell lymphomas'] @entity42424 :: ('MESH:D016410', 'Disease') :: ['cutaneous follicle center cell lymphoma']
@entity42424 :: (MESH:D016410,Disease) :: ['cutaneous follicle center cell lymphoma']
